Skip to main content

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Investor Securities Class Action Lawsuit 09/25/2020

  •  

    You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of October 30, 2023, by which all claims must be submitted. The instructions for submitting are included in the "Proof" and the "Notice" files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC..

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

June 8, 2023 - The court granted preliminary approval of the settlement. April 24, 2023 - The parties entered into a stipulation and agreement of settlement. January 6, 2022 - The court denied the defendants' motion to dismiss. April 22, 2021 - A motion to dismiss the amended complaint was filed. February 22, 2021 - An amended complaint was filed. September 25, 2020 - An investor in s...



You must register (for free) or login to view the entire case.